Current filters:


8526 to 8535 of 95882 results

Executive appointments at Bristol-Myers Squibb and Amgen


US drug major Bristol-Myers Squibb (NYSE: BMY) has announced a series of related changes within its senior…

AmgenBiotechnologyBristol-Myers SquibbManagementPharmaceutical

Benefits of Boehringer’s Pradaxa come at high cost, study finds


Treating patients with the new blood thinning medication dabigatran (German independent drug major Boehringer…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaPricing

Prasco selected as Eli Lilly authorized generics partner for Zyprexa


Privately-held US drugmaker Prasco Laboratories says it has signed a marketing and distribution agreement…

Eli LillyGenericsMarkets & MarketingNeurologicalNorth AmericaPrasco LaboratoriesZyprexa

Over 230K US pharma jobs will be lost under proposed mandatory Part D drug rebates, says think tank


US President Barack Obama and some members of Congress have proposed requiring that prescription drug…

HealthcareNorth AmericaPharmaceuticalPoliticsPricingResearch

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Atrial fibrillation drug market to increase nearly eight-fold to over $10 billion in 2020


The atrial fibrillation drug market will increase nearly eight-fold over the next decade, growing from…

Cardio-vascularEliquisGlobalMarkets & MarketingPharmaceuticalPradaxaXarelto

Litigation hits Abbott Lab’s 3rd-qtr, but shares leap as firm says it will split in two


US health care major Abbott Laboratories (NYSE: ABT) saw its shares leap 10% in morning trading yesterday,…

Abbott LaboratoriesFinancialPharmaceutical

GlaxoSmithKline warned by US FDA over cGMP violations at UK plant; positive malaria vaccine news


UK pharma giant GlaxoSmithKline ILSE: GSK) has received a warning letter from the US Food and Drug Administration…

Antibiotics and Infectious diseasesGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

Servier links with Miragen for cardiovascular drugs; takes up Ampakine option


Laboratoires Servier , France’s largest independent drugmaker has entered into a research, development…

Cardio-vascularCortex PharmaceuticalsLicensingmiRagen TherapeuticsNeurologicalPharmaceuticalServier

8526 to 8535 of 95882 results

Company Spotlight



Back to top